Selected research
Industry Research
Bioprocess Platform Software Industry Research Report 2026
Market perspective
The global Bioprocess Platform Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Bioprocess Platform Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Bioprocess Platform Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Bioprocess Platform Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Bioprocess Platform Software include Eppendorf, BioReact, Infors AG, Thermo Fisher Scientific, Invert, Genedata, Novasign, Qubicon and BioRaptor, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Bioprocess Platform Software market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Bioprocess Platform Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bioprocess Platform Software Market by Company
Eppendorf
BioReact
Infors AG
Thermo Fisher Scientific
Invert
Genedata
Novasign
Qubicon
BioRaptor
Merck
Bionet
Securecell
Vimachem
Scientific Industries
Bioprocess Platform Software Segment by Type
Cloud-based
On-premise
Bioprocess Platform Software Segment by Application
Upstream Processing (Cell Culture/Fermentation)
Downstream Processing (Purification)
Bioprocess Platform Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioprocess Platform Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioprocess Platform Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioprocess Platform Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bioprocess Platform Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-premise
Applications
- Upstream Processing (Cell Culture/Fermentation)
- Downstream Processing (Purification)
Companies covered
- Eppendorf
- BioReact
- Infors AG
- Thermo Fisher Scientific
- Invert
- Genedata
- Novasign
- Qubicon
- BioRaptor
- Merck
- Bionet
- Securecell
- Vimachem
- Scientific Industries
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bioprocess Platform Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-based
- 2.2.3 On-premise
- 2.3 Bioprocess Platform Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Upstream Processing (Cell Culture/Fermentation)
- 2.3.3 Downstream Processing (Purification)
- 2.4 Assumptions and Limitations
3 Bioprocess Platform Software Breakdown Data by Type
- 3.1 Global Bioprocess Platform Software Historic Market Size by Type (2021-2026)
- 3.2 Global Bioprocess Platform Software Forecasted Market Size by Type (2027-2032)
4 Bioprocess Platform Software Breakdown Data by Application
- 4.1 Global Bioprocess Platform Software Historic Market Size by Application (2021-2026)
- 4.2 Global Bioprocess Platform Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Bioprocess Platform Software Market Perspective (2021-2032)
- 5.2 Global Bioprocess Platform Software Growth Trends by Region
- 5.2.1 Global Bioprocess Platform Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Bioprocess Platform Software Historic Market Size by Region (2021-2026)
- 5.2.3 Bioprocess Platform Software Forecasted Market Size by Region (2027-2032)
- 5.3 Bioprocess Platform Software Market Dynamics
- 5.3.1 Bioprocess Platform Software Industry Trends
- 5.3.2 Bioprocess Platform Software Market Drivers
- 5.3.3 Bioprocess Platform Software Market Challenges
- 5.3.4 Bioprocess Platform Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Bioprocess Platform Software Players by Revenue
- 6.1.1 Global Top Bioprocess Platform Software Players by Revenue (2021-2026)
- 6.1.2 Global Bioprocess Platform Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Bioprocess Platform Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bioprocess Platform Software Head Office and Area Served
- 6.4 Global Bioprocess Platform Software Players, Product Type & Application
- 6.5 Global Bioprocess Platform Software Manufacturers Established Date
- 6.6 Global Bioprocess Platform Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Bioprocess Platform Software Market Size (2021-2032)
- 7.2 North America Bioprocess Platform Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Bioprocess Platform Software Market Size by Country (2021-2026)
- 7.4 North America Bioprocess Platform Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Bioprocess Platform Software Market Size (2021-2032)
- 8.2 Europe Bioprocess Platform Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Bioprocess Platform Software Market Size by Country (2021-2026)
- 8.4 Europe Bioprocess Platform Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Bioprocess Platform Software Market Size (2021-2032)
- 9.2 Asia-Pacific Bioprocess Platform Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Bioprocess Platform Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Bioprocess Platform Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Bioprocess Platform Software Market Size (2021-2032)
- 10.2 South America Bioprocess Platform Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Bioprocess Platform Software Market Size by Country (2021-2026)
- 10.4 South America Bioprocess Platform Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Bioprocess Platform Software Market Size (2021-2032)
- 11.2 Middle East & Africa Bioprocess Platform Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Bioprocess Platform Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Bioprocess Platform Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eppendorf
- 12.1.1 Eppendorf Company Information
- 12.1.2 Eppendorf Business Overview
- 12.1.3 Eppendorf Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.1.4 Eppendorf Bioprocess Platform Software Product Portfolio
- 12.1.5 Eppendorf Recent Developments
- 12.2 BioReact
- 12.2.1 BioReact Company Information
- 12.2.2 BioReact Business Overview
- 12.2.3 BioReact Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.2.4 BioReact Bioprocess Platform Software Product Portfolio
- 12.2.5 BioReact Recent Developments
- 12.3 Infors AG
- 12.3.1 Infors AG Company Information
- 12.3.2 Infors AG Business Overview
- 12.3.3 Infors AG Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.3.4 Infors AG Bioprocess Platform Software Product Portfolio
- 12.3.5 Infors AG Recent Developments
- 12.4 Thermo Fisher Scientific
- 12.4.1 Thermo Fisher Scientific Company Information
- 12.4.2 Thermo Fisher Scientific Business Overview
- 12.4.3 Thermo Fisher Scientific Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.4.4 Thermo Fisher Scientific Bioprocess Platform Software Product Portfolio
- 12.4.5 Thermo Fisher Scientific Recent Developments
- 12.5 Invert
- 12.5.1 Invert Company Information
- 12.5.2 Invert Business Overview
- 12.5.3 Invert Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.5.4 Invert Bioprocess Platform Software Product Portfolio
- 12.5.5 Invert Recent Developments
- 12.6 Genedata
- 12.6.1 Genedata Company Information
- 12.6.2 Genedata Business Overview
- 12.6.3 Genedata Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.6.4 Genedata Bioprocess Platform Software Product Portfolio
- 12.6.5 Genedata Recent Developments
- 12.7 Novasign
- 12.7.1 Novasign Company Information
- 12.7.2 Novasign Business Overview
- 12.7.3 Novasign Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.7.4 Novasign Bioprocess Platform Software Product Portfolio
- 12.7.5 Novasign Recent Developments
- 12.8 Qubicon
- 12.8.1 Qubicon Company Information
- 12.8.2 Qubicon Business Overview
- 12.8.3 Qubicon Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.8.4 Qubicon Bioprocess Platform Software Product Portfolio
- 12.8.5 Qubicon Recent Developments
- 12.9 BioRaptor
- 12.9.1 BioRaptor Company Information
- 12.9.2 BioRaptor Business Overview
- 12.9.3 BioRaptor Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.9.4 BioRaptor Bioprocess Platform Software Product Portfolio
- 12.9.5 BioRaptor Recent Developments
- 12.10 Merck
- 12.10.1 Merck Company Information
- 12.10.2 Merck Business Overview
- 12.10.3 Merck Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.10.4 Merck Bioprocess Platform Software Product Portfolio
- 12.10.5 Merck Recent Developments
- 12.11 Bionet
- 12.11.1 Bionet Company Information
- 12.11.2 Bionet Business Overview
- 12.11.3 Bionet Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.11.4 Bionet Bioprocess Platform Software Product Portfolio
- 12.11.5 Bionet Recent Developments
- 12.12 Securecell
- 12.12.1 Securecell Company Information
- 12.12.2 Securecell Business Overview
- 12.12.3 Securecell Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.12.4 Securecell Bioprocess Platform Software Product Portfolio
- 12.12.5 Securecell Recent Developments
- 12.13 Vimachem
- 12.13.1 Vimachem Company Information
- 12.13.2 Vimachem Business Overview
- 12.13.3 Vimachem Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.13.4 Vimachem Bioprocess Platform Software Product Portfolio
- 12.13.5 Vimachem Recent Developments
- 12.14 Scientific Industries
- 12.14.1 Scientific Industries Company Information
- 12.14.2 Scientific Industries Business Overview
- 12.14.3 Scientific Industries Revenue in Bioprocess Platform Software Business (2021-2026)
- 12.14.4 Scientific Industries Bioprocess Platform Software Product Portfolio
- 12.14.5 Scientific Industries Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst